British drugmaker GSK has agreed to acquire U.S. cancer-focused biotechnology company Nuvalent for $10.6 billion, strengthening its oncology portfolio with three experimental lung cancer treatments. The deal, announced on Tuesday, includes two late-stage therapies, zidesamtinib and neladalkib, which GSK said could be launched before the end of 2026, which is subject to regulatory approval. GSK...
FlashNews:
Peter Obi Accuses Benue Official Of Blocking Convoy
Christmas Arrives Early In The Philippines As ‘Ber Months’ Begin
Russia, N.Korea Open First Road Bridge Across Border
Oyetola Confirms 20 Of 92 Applications Await Approval For CVFF Disbursement
Nigeria, IEA Sign Agreement to Strengthen Energy Partnership
Guinea Bissau Votes ‘Yes’ In Referendum For New Constitution
Zambia’s Hichilema Sworn In For A Second Term
IMF Reaches Agreement With Senegal On New $2.2 Bn Loan Programme
Nepal’s Wall Of Missing Offers Last Hope After Himalayan Flood
Putin Urges Conflict Prevention At SCO Summit In Bishkek
Fast-Fashion Giant Shein Plunges 10% On Hong Kong Debut
Nepal Says Death Toll Rises To 987, Bringing Total Killed Past 1,000
Duane “Keffe D” Davis Former Gang Member Found Guilty Of Murdering Tupac Shakur
Record US$947m July Remittances Bring Cardoso’s US$1bn Monthly Target Within Sight
Nigeria Takes Xenophobic Attacks In South Africa To African Union
Guinea-Bissau Votes In Referendum On Giving President More Powers
Syrian Embassy Reopens After 14 Years Of Diplomatic Break
China Penalises 10 People For Misinformation Over Deadly Mudslide
Poorly Djokovic Crashes Out Of US Open First Round
Home » Pharmaceutical